Ticker | Company | Price | Valuation Score | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
KRYS | KRYSTAL BIOTECH INC | $177.93 | $9.60 | 1,752.90% | 444.83x | -62.87x | 95.30x | 6.47x | 8.41x | -$603.00k | -0.01% | $778.64M | 28.68 | $4.68B | 261.61 | |
GMAB | GENMAB A | $29.91 | $21.65 | 38.15% | 30.84x | 18.13x | 8.24x | 4.30x | 0.64x | $1.02B | 5.16% | $4.60B | 6.96 | $17.71B | N/A | |
TGTX | TG THERAPEUTICS INC | $15.21 | $4.88 | 211.97% | 169.00x | -22.70x | 9.24x | 14.63x | 1.22x | -$31.41M | -1.45% | $160.50M | 1.13 | $2.36B | 91.31 | |
HALO | HALOZYME THERAPEUTICS INC | $40.68 | $47.87 | -15.03% | 19.10x | 9.97x | 6.47x | 61.56x | 0.39x | $373.28M | 6.95% | $83.81M | 0.64 | $6.54B | 14.47 | |
BMRN | BIOMARIN PHARMACEUTICAL INC | $87.34 | $34.39 | 153.97% | 98.13x | 31.08x | 6.78x | 3.33x | 1.04x | $62.57M | 0.38% | $4.95B | 26.36 | $16.81B | 54.18 | |
INCY | INCYTE CORP | $56.97 | $63.97 | -10.95% | 21.34x | 9.59x | 3.45x | 2.46x | 0.40x | $464.00M | 3.64% | $5.19B | 23.21 | $9.61B | 10.45 | |
MDXG | MIMEDX GROUP INC | $7.70 | $5.76 | 33.66% | 19.25x | 154.00x | 2.79x | 7.93x | 0.76x | $24.79M | 2.77% | $142.72M | 1.23 | $1.10B | 33.70 | |
CORT | CORCEPT THERAPEUTICS INC | $25.19 | $16.30 | 54.52% | 24.70x | 17.99x | 5.41x | 5.15x | 0.82x | $126.90M | 4.86% | $506.71M | 4.89 | $2.47B | 22.68 | |
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.58 | $43.85 | -23.42% | 15.47x | 8.70x | 3.43x | 4.08x | 0.37x | $219.08M | 10.97% | $466.99M | 7.85 | $1.79B | 8.07 | |
RPRX | ROYALTY PHARMA PLC | $30.37 | $41.84 | -27.41% | 11.96x | 7.54x | 5.77x | 1.80x | 0.38x | $2.98B | 21.89% | $10.08B | 22.53 | $23.80B | 18.00 | |
VNDA | VANDA PHARMACEUTICALS INC | $4.11 | $1.65 | 149.32% | 102.75x | 15.22x | 1.22x | 0.43x | 1.01x | $12.42M | 5.26% | $544.91M | 9.50 | $107.66M | 11.52 | |
TECH | BIO-TECHNE CORP | $70.39 | $22.21 | 216.88% | 49.92x | 29.21x | 9.68x | 5.64x | 1.70x | $225.39M | 2.03% | $1.96B | 12.46 | $11.49B | 30.81 | |
EXEL | EXELIXIS INC | $23.73 | $16.22 | 46.27% | 36.51x | 14.74x | 4.12x | 3.18x | 0.66x | $292.86M | 3.88% | $2.26B | 7.12 | $7.12B | 22.81 | |
JAZZ | JAZZ PHARMACEUTICALS PLC | $120.42 | $183.41 | -34.34% | 18.38x | 4.96x | 1.99x | 2.01x | 0.29x | $1.07B | 14.01% | $3.74B | 59.05 | $11.77B | 9.63 | |
PBYI | PUMA BIOTECHNOLOGY INC | $5.30 | $7.14 | -25.81% | 11.52x | 8.41x | 1.06x | 4.78x | 0.40x | $26.87M | 10.75% | $53.44M | 1.13 | $282.40M | 5.94 | |
BNTX | BIONTECH SE | $92.25 | $77.34 | 19.28% | 21.93x | 19.46x | 5.28x | 1.00x | 0.60x | $5.07B | 23.13% | $22.01B | 92.57 | $9.98B | 6.59 | |
AMLX | AMYLYX PHARMACEUTICALS INC | $2.84 | $40.38 | -92.97% | 3.89x | 0.93x | 0.50x | 0.44x | 0.03x | $10.68M | 5.60% | $433.43M | 6.45 | $25.82M | 0.47 | |
CPRX | CATALYST PHARMACEUTICALS INC | $15.94 | $7.55 | 111.07% | 23.79x | 17.71x | 4.25x | 4.84x | 1.44x | $143.37M | 8.46% | $387.88M | 3.65 | $1.74B | 13.66 | |
NVO | NOVO NORDISK A S | $128.40 | $19.45 | 560.24% | 47.24x | 52.95x | 17.13x | 37.33x | 9.92x | $12.10B | 2.09% | $15.51B | 3.44 | $580.92B | 34.87 | |
UTHR | UNITED THERAPEUTICS CORP | $229.72 | $180.11 | 27.54% | 10.92x | 11.90x | 4.62x | 1.81x | 1.24x | $747.60M | 6.95% | $5.98B | 127.88 | $10.30B | 7.43 | |
REGN | REGENERON PHARMACEUTICALS INC | $962.49 | $266.18 | 261.59% | 25.98x | 23.68x | 7.83x | 4.07x | 5.36x | $3.88B | 3.77% | $25.97B | 243.42 | $105.62B | 22.50 | |
VRTX | VERTEX PHARMACEUTICALS INC | $418.01 | $89.18 | 368.71% | 29.75x | 30.76x | 10.91x | 6.14x | 12.12x | $3.34B | 3.10% | $17.58B | 68.22 | $98.33B | 21.35 |